2023 ATIP Recipients
Fernando Goes, MD
“EEG Gamma Activity as a Biomarker of Rapid Antidepressant Action”
Scott Krummey, MD, PhD
“HLA Epitope Mismatch Analysis in Transplantation: Development of an Immunoassay to Detect Pathogenic HLA Class II Antibodies in Transplant Patients”
Ying Zou, MD, PhD, FACMG
“Rapid CRISPR/Cas9-mediated Nanopore Flongle Sequencing to Detect PML::RARA Fusion in Acute Promyelocytic Leukemia”
2022 ATIP Recipients
Michael Koldobskiy, MD, PhD
“Novel Anthracycline Analogues for Therapy of Histone-mutant Pediatric Glioma”
Jonathan Webster, MD
“Advancing Decitabine Genomic Incorporation as A Novel Pharmacodynamic and Response-predictive Biomarker in Myeloid Malignancies: A Focus on DNMT Inhibition Combined with Agents Targeting the p53/MDM2 Pathway and A Corollary to NCT03041688”
Jonathan Webster, MD
“CRISPRi/a Screen to Identify Molecular Pathways and Targets that Modulate RPE-EMT: An Approach for the Treatment of Atrophic (Dry) AMD”
2021 ATIP Recipients
Chad Gordon, DO
“MRI-Compatible Skull-Embedded Implant for Chronic & Direct Medicine Delivery to Treat Neurologic Pathology”
Robert Stevens, MD
“Computational Subphenotype Discovery and Treatment Response Prediction in Traumatic Brain Injury”
Trish Simner, PhD
“Clinical Translation of Nanopore Metagenomic Next-Generation Sequencing for Pathogen Identification”
